In MDA-MB-231 cells, CCL2 gene silencing led to inhibition of CCL2 expression, which—in turn—led to the significant inhibition of tumor growth, cell proliferation, and increased necrosis [99,114]. The gene discussed is CCL2; the disease is neoplasm.